Author

Hema Preethi Subas Satish

Observed names: H. Subas-Satish, Hema P. Subas-Satish, S. S. Hema Preethi, Subas Satish, Hema Preethi

Institution: Walter and Eliza Hall Institute of Medical Research

Observed institutions: The University of Queensland, The University of Melbourne, Walter and Eliza Hall Institute of Medical Research, Vanderbilt University Medical Center

ORCID: 0000-0003-0626-8764

Observed ORCID: 0000-0003-0626-8764

OpenAlex ID: A5012467119

NAb-seq: an accurate, rapid, and cost-effective method for antibody long-read sequencing in hybridoma cell lines and single B cells

2022 · Hema Preethi Subas Satish, Kathleen Zeglinski, et al. · mAbs · 22

Effect of Chain‐End Chemistries on the Efficiency of Coupling Antibodies to Polymers Using Unnatural Amino Acids

2020 · Amal J. Sivaram, Andri Wardiana, et al. · Macromolecular Rapid Communications · 7

A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells

2024 · Hema Preethi Subas Satish, Sweta Iyer, et al. · Cell Death and Differentiation · 6

Abstract 1382: The discovery of a novel antibody, 14G6, as a tool for understanding BAK conformational dynamics and their relationship to venetoclax response in leukemia

2025 · Michelle S. Miller, Hema P. Subas-Satish, et al. · Cancer Research

Structure of the BAK- inhibiting antibody 14G6 bound to BAK identifies core–latch separation and α1-dissociation as essential events in BAK activation

2023 · M. S. Miller, H. Subas-Satish, et al. · Acta Crystallographica Section A Foundations and Advances

Engineering antibodies to trigger Bak-mediated apoptosis in cancer

2022 · Subas Satish, Hema Preethi · Minerva Access (University of Melbourne)

Works count: 6

Citation count: 35

H-index: 3

I10-index: 1